China continues its recent trend of reforming its regulatory system to make it more attractive for Western companies to introduce innovative technologies to the Chinese market. This presents a window, particularly for small to mid-sized companies, to access what historically has been a difficult market to crack.

Read the full article: https://bit.ly/3AGxCc9

View the latest issue of Market Pathways: https://bit.ly/2UEqmO9
View more podcast episodes: https://bit.ly/3jMx65s

About Market Pathways

Your premium guide to global medical device regulation, reimbursement and policy. Market Pathways delivers incomparable intelligence exploring the people, challenges, and opportunities impacting the global medtech regulatory and reimbursement community. View the latest issue of Market Pathways on MyStrategist.com